Skip to main content

Articles

Page 1 of 5

  1. Dipeptidyl peptidase-4 inhibitors (DPP-4is) have been hypothesized to impact COVID-19 outcomes by modulating immune and inflammatory responses. This study aimed to assess the association between DPP-4i use and...

    Authors: El Walid El Hassan, Ahmad Alamer, Sarah Saad Alnami, Ibrahem Abdullah Alhawaj, Ali Hussain Alsmail, Mohammed Abdulhadi Alshawaf, Muhammad Abdulhaddi Aljazeeri, Maram Jafar Alghafli, Fatimah Yahya Alhejji, Osamah M. Alfayez, Mayar Mohammed Alharthi, Hamzah Redha Alturfi, Maha Fahad AlEssa, Rahaf Hamoud Alzuman, Sawsan M. Kurdi, Omar A. Almohammed…
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:9
  2. The objective of this report is to describe the successful use of diazoxide as a bridging therapy for a patient with opioid-induced hypoglycemia who was unable to immediately discontinue methadone treatment.

    Authors: Katherine I. Wolf, Sophia Hemmrich Sinha, Shafaq Khairi and Eric D. Buras
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:7
  3. Prolactinomas are the most common type of pituitary adenomas, typically managed with dopamine agonists. However, some cases are refractory to standard therapies, posing significant clinical challenges. This ca...

    Authors: Firdhous Alimathunisa Abdul Kather, Ariel Barkan and Shafaq Khairi
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:8
  4. Obesity is a chronic metabolic disease of global concern, often associated with Type 2 Diabetes Mellitus (T2DM). Global guidelines recommend holistic approach for T2DM management by addressing the associated c...

    Authors: Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, Manash P. Baruah, Abhishek Mane, Sanjay Choudhari, Anup Petare, Mayur Jadhav, Saiprasad Patil and Hanmant Barkate
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:6
  5. The COVID-19 pandemic has impacted the lives of many including individuals living with chronic illnesses such as Type 2 Diabetes Mellitus (T2DM) in Ghana. This study aimed to explore how people living with T2D...

    Authors: Margaret Amankwah-Poku, Genevieva Gordon-Mensah and Kwaku Oppong Asante
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:5
  6. More information is required where the relation of diabetic neuropathy and body composition through bioimpedance is addressed. Therefore the aim of this study was to investigate the association between periphe...

    Authors: María Fernanda Garcés Pérez, Juan Enrique Santos Macías, Arnulfo González Cantú, Arnulfo Garza-Silva, Miguel Ángel Sanz Sánchez and María Elena Romero-Ibarguengoitia
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:4
  7. Type 2 diabetes is among the most prevalent endocrine disruptors. One of the most significant symptoms reported by diabetic patients is dry mouth, which results in reduced saliva buffering capacity and an incr...

    Authors: Forough Ahrari, Hamidreza Zivarifar, Tahereh Ahrari Roodi and Leili Alizadeh
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:2
  8. Gestational diabetes mellitus (GDM) cases are rising globally. This research examined the effects of GDM and diabetes mellitus whose hallmark is hyperglycemia on hormones, lipid profiles, electrolytes and anti...

    Authors: Moses Orimoloye Akinjiyan, Adeniran Samuel Atiba and Modupe Fisayo Asaolu
    Citation: Cardiovascular Diabetology – Endocrinology Reports 2025 11:1
  9. Thyroid dysfunction in pregnancy can adversely impact maternal and fetal outcomes. However, the association between thyroid status and specific adverse outcomes needs clarity, especially in understudied regions.

    Authors: Roshni Vamja, Yogesh M, Monika Patel, Vijay Vala, Arya Ramachandran, Bhumika Surati and Jay Nagda
    Citation: Clinical Diabetes and Endocrinology 2024 10:50
  10. The ICMR INDIAB-17 study revealed a diabetes prevalence of 11.4% in India, emphasizing the need for effective treatment for glycemic control. A Phase IV study was conducted to evaluate the safety and efficacy ...

    Authors: Prabhat K Agarwal, Divendu Bhushan, Amit Bhate, Sunil Naik, Shailesh Adwani, J S Kushwaha, Sumit Bhushan, Abhishek Mane, Rujuta Gadkari, Sanjay Choudhari, Saiprasad Patil and Hanmant Barkate
    Citation: Clinical Diabetes and Endocrinology 2024 10:49
  11. This meta-analysis study aims to evaluate the Diabetes Self-Management Education and Support (DSMES) online application for reducing glycated hemoglobin levels among patients with type 1 diabetes mellitus (T1D...

    Authors: Sahebeh Usefi, Fereshteh Davoodi, Atefeh Alizadeh and Mehrshad Mohebi Far
    Citation: Clinical Diabetes and Endocrinology 2024 10:48
  12. This study aimed to determine the prevalence of Normal Weight Obesity (NWO) and evaluate its association with cardiometabolic risk factors among patients with Type 2 Diabetes Mellitus (T2DM) in Gujarat, India.

    Authors: M. Yogesh, Mansi Mody, Naresh Makwana and Jenish Patel
    Citation: Clinical Diabetes and Endocrinology 2024 10:47
  13. Metabolic-associated fatty liver disease (MAFLD) is a major public health problem worldwide. This study aimed to determine the prevalence of MAFLD and evaluate the diagnostic accuracy of the Fatty Liver Index ...

    Authors: Roshni Vamja, Yogesh M, Vijay Vala, Arya Ramachandran and Jay Nagda
    Citation: Clinical Diabetes and Endocrinology 2024 10:46
  14. The literature has been evolving to standardize gestational diabetes mellitus (GDM) diagnosis and terminology. The significance of timing in diagnosing hyperglycemia during pregnancy is underlined by evidence ...

    Authors: Fabiana Vieira Duarte de Souza Reis, Carlos Izaias Sartorão Filho, Luis Sobrevia, Caroline Baldini Prudencio, Bruna Bologna, Luana Favaro Iamundo, Adriely Magyori, Luiz Takano, Raissa Escandiussi Avramidis, Rafael Guilen de Oliveira, Marilza Vieira Cunha Rudge and Angélica Mércia Pascon Barbosa
    Citation: Clinical Diabetes and Endocrinology 2024 10:45
  15. Diabetes distress “refers to the negative emotional or affective experiences resulting from the challenge of living with the demands of diabetes.” Despite recommendations to screen for distress at regular interva...

    Authors: Anam Anil Alwani, Ravneet Kaur, Mohan Bairwa, Puneet Misra and Baridalyne Nongkynrih
    Citation: Clinical Diabetes and Endocrinology 2024 10:40
  16. Type 2 diabetes mellitus (T2DM) is a major global non-communicable disease, leading to increased morbidity and mortality. Its prevalence in Nigeria is driven by various risk factors. This review assesses the n...

    Authors: Michael Adeyemi Olamoyegun, Kehinde Alare, Samson Adedeji Afolabi, Nicholas Aderinto and Taiwo Adeyemi
    Citation: Clinical Diabetes and Endocrinology 2024 10:43
  17. Effective diabetic retinopathy screening (DRS) programmes are important in preventing vision impairment and blindness caused by diabetes. This study focuses on identifying the factors affecting attendance or n...

    Authors: Katie Curran, Munir Ahmed, Mirza Manbira Sultana, Salissou Moutari, Mohammad Awlad Hossain, Laura Cushley, Tunde Peto, Lutful Husain, Bedowra Zabeen and Nathan Congdon
    Citation: Clinical Diabetes and Endocrinology 2024 10:41
  18. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern and the risk of its development is connected with the increasing prevalence of metabolic syndrome (MetS) which occur...

    Authors: Bruno Basil, Blessing K. Myke-Mbata, Onyinye E. Eze and Augustine U. Akubue
    Citation: Clinical Diabetes and Endocrinology 2024 10:39
  19. Monacolin-K, the active component of red yeast rice (RYR), reduces cholesterol by inhibiting HMG-CoA reductase. Following safety concerns, the European Food Safety Authority (EFSA) recommended limiting Monacol...

    Authors: Alessia Izzo, Rosa Costanzo, Lucia De Martino and Salvatore Di Napoli
    Citation: Clinical Diabetes and Endocrinology 2024 10:38
  20. Propylthiouracil is an antithyroid medication that is associated with ANCA positivity, often in the absence of clinically overt vasculitis. Propylthiouracil-induced ANCA-associated vasculitis (AAV) is characte...

    Authors: Ro’a Khalaf, Deema Mhesin, Hasan Abu Salim, Sari Taha and Waddah Abed
    Citation: Clinical Diabetes and Endocrinology 2024 10:42
  21. Type 2 diabetes mellitus (T2DM) is a multifaceted metabolic disorder. Over the past decade, the potential role of Growth Hormone (GH) and Insulin-like Growth Factor-1 (IGF-1) in the pathogenesis and progressio...

    Authors: Hasanain MohammedHuthaifa AbdlWhab, Araz Al-Saffar, Osama Abbas Mahdi and Rafid Badri Alameri
    Citation: Clinical Diabetes and Endocrinology 2024 10:36
  22. We present one of only seven reported cases of a catecholamine-secreting adrenal neuroblastoma in an adult. The case is used as a platform to discuss key biochemical, genomic and imaging considerations that ar...

    Authors: Joanna Y. Gong, Debbie Gordon, Sylvia Ye, Bill Fleming, Jason Tan, Toby Hulf, Maryam Shamassi, Lisa M. Orme, Nezor Houli, Emma Boehm, Christopher J. Yates and Dev A. Kevat
    Citation: Clinical Diabetes and Endocrinology 2024 10:37
  23. Diabetes mellitus (DM) is one of the most prevalent chronic diseases worldwide. Despite the existence of national strategies to prevent potential complications, DM-related morbidities and mortality continue to...

    Authors: Sentayehu Admasu Saliya, Taye Mezgebu Ashine, Asnakech Zekiwos Heliso, Getachew Ossabo Babore, Bethelhem Birhanu, Awoke Girma Hailu, Sisay Foga Sebro, Elias Ezo and Selamawit Wondale Begizew
    Citation: Clinical Diabetes and Endocrinology 2024 10:34
  24. Sarcopenia is defined by low measures of muscle quantity, quality and reduced physical performance. It is associated with higher levels of frailty. Individuals with diabetes mellitus (DM) undergo sarcopenia at...

    Authors: Manal Ahmad, Abdulla Mohamed, Dimitri Amiras, Francesca Siracusa, Joseph Shalhoub and Alun Huw Davies
    Citation: Clinical Diabetes and Endocrinology 2024 10:31
  25. Constipation, which affects 16% of adults worldwide, is a chronic health problem characterized by unsatisfactory frequency of bowel movements, causing pain, bloating or incomplete bowel movements. The study ai...

    Authors: Wubshet Nebiyu Mogess, Tefera Belsty Mihretie, Mezgebu Legesse Habte, Teka Obsa Feyisa, Bilisuma Girma Areda, Ebsa Tofik Ahmed, Getahun Chala Diribsa, Mastewal Zeleke, Natan Muluberhan Alemseged, Eyobel Amentie, Tegenu Balcha Wodajo and Tewekel Reshid Borushe
    Citation: Clinical Diabetes and Endocrinology 2024 10:33
  26. There are scant data relating to prognostic biomarkers for chronic kidney disease (CKD) complicating type 1 diabetes. The aim of this study was to assess the performance of the plasma protein biomarker-based P...

    Authors: Timothy M. E. Davis, Wendy A. Davis, Scott D. Bringans, James K. C. Lui, Tasha S. C. Lumbantobing, Kirsten E. Peters and Richard J. Lipscombe
    Citation: Clinical Diabetes and Endocrinology 2024 10:30
  27. Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder affecting women of reproductive age, characterised by its multifactorial nature and intricate interplay of genetic, hormonal, and environmenta...

    Authors: Emmanuel Kokori, Gbolahan Olatunji, Rosemary Komolafe, Ikponmwosa Jude Ogieuhi, Bonaventure Ukoaka, Irene Ajayi and Nicholas Aderinto
    Citation: Clinical Diabetes and Endocrinology 2024 10:27
  28. Obesity is rising globally. Normal weight obesity (NWO) and normal weight central obesity (NWCO) despite normal BMI pose added metabolic risks. Limited data on these phenotypes among Indian doctors merits inve...

    Authors: Yogesh M, Nidhi Trivedi, Naresh Makwana, Pagadala Hari Priya PVM Krishna and Kadalarasu D
    Citation: Clinical Diabetes and Endocrinology 2024 10:28
  29. Ceramides have recently been identified as novel biomarkers associated with diabetes mellitus (DM) and major adverse cardiac and cerebrovascular events (MACCE). This study aims to explore their utility in diag...

    Authors: Debora Leonor Junqueira, Alexandre Biasi Cavalcanti, Juliana Maria Ferraz Sallum, Erika Yasaki, Isabella de Andrade Jesuíno, Alline Stach, Karina Negrelli, Leila de Oliveira Silva, Marcela Almeida Lopes, Adriano Caixeta, Mark YY Chan, Jianhong Ching, Valdemir Malechco Carvalho, Andrea Tedesco Faccio, Jeane Tsutsui, Edgar Rizzatti…
    Citation: Clinical Diabetes and Endocrinology 2024 10:32
  30. Type 1 diabetes mellitus (T1D) is an autoimmune disease caused by destruction of pancreatic islet beta-cells. There is significant residual beta-cell function, measured through circulating C-peptide, present a...

    Authors: Adya Rao, Lauren M Quinn and Parth Narendran
    Citation: Clinical Diabetes and Endocrinology 2024 10:26

    The Correction to this article has been published in Cardiovascular Diabetology – Endocrinology Reports 2025 11:3

  31. Elevated blood glucose concentration, also known as hyperglycemia, has been identified as a significant factor influencing the prognosis of COVID-19, alongside the impact of the SARS-CoV-2 infection itself.

    Authors: Faranak Salajegheh, Somayyeh Salajegheh, Mohsen Nakhaie, Niloofar Farsiu, Seyedeh Mahdieh Khoshnazar, Reza Sinaei, Mehrdad Farrokhnia and Soheila Torabiyan
    Citation: Clinical Diabetes and Endocrinology 2024 10:29
  32. Thyroid storm is a medical emergency with a high mortality rate. Acute liver failure (ALF) and disseminated intravascular coagulation (DIC) are rarely reported with thyroid storm, and their occurrence is unrel...

    Authors: Manudi Vidanapathirana and Dilushi Wijayaratne
    Citation: Clinical Diabetes and Endocrinology 2024 10:24
  33. Hungry bone syndrome (HBS) is defined as prolonged hypocalcemia caused by a sudden decrease in parathyroid hormone (PTH) levels after parathyroidectomy (PTX). Multiple fractures after PTX due to HBS in an end-...

    Authors: Farnaz Tavakoli, Fatemeh Yaghoubi, Davood Dalil and Mahdi Rezaei
    Citation: Clinical Diabetes and Endocrinology 2024 10:25
  34. This review explores the immunomodulatory potential of Teplizumab and its impact on pancreatic β-cell function in T1D. Characterized by the autoimmune destruction of insulin-producing beta cells, T1D’s managem...

    Authors: Emmanuel Kokori, Gbolahan Olatunji, Ikponmwosa Jude Ogieuhi, John Ehi Aboje, Doyin Olatunji, Sikiru Ademola Aremu, Stephen Chukwuemeka Igwe, Abdulrahmon Moradeyo, Yusuf Ismaila Ajayi and Nicholas Aderinto
    Citation: Clinical Diabetes and Endocrinology 2024 10:23
  35. Type 2 diabetes is increasing in Sub-Saharan Africa, but the pathophysiology in this population is poorly investigated. In Western populations, the incretin effect is reduced in type 2 diabetes, leading to low...

    Authors: Signe Tellerup Nielsen, Belinda Kweka, George Praygod, Suzanne Filteau, Mette Frahm Olsen, Henrik Friis, Daniel Faurholt-Jepsen and Rikke Krogh-Madsen
    Citation: Clinical Diabetes and Endocrinology 2024 10:20
  36. Type 2 diabetes disproportionately affects non-Hispanic/Latino Black and Hispanic/Latino youth. The purpose of this study was to examine whether differences in metabolic risk factors and depressive symptoms ex...

    Authors: Carolina M. Bejarano, Sanita Ley, Nisha Krishnan, Sarah Orkin, Nancy A. Crimmins, Lisa Schaaf and Amy S. Shah
    Citation: Clinical Diabetes and Endocrinology 2024 10:21
  37. Diabetic foot ulcers (DFU) are a costly complication of diabetes mellitus (DM), with significant implications for the patient and the healthcare professionals that treat them. The primary objective of this stu...

    Authors: Brennen O’Dell, Gary Rothenberg, Crystal Holmes, Sari Priesand, Kara Mizokami-Stout, Eric J. Brandt and Brian M. Schmidt
    Citation: Clinical Diabetes and Endocrinology 2024 10:19
  38. Gestational Diabetes Mellitus (GDM) poses significant health risks to mothers and infants. Early prediction and effective management are crucial to improving outcomes. Machine learning techniques have emerged ...

    Authors: Emmanuel Kokori, Gbolahan Olatunji, Nicholas Aderinto, Ifeanyichukwu Muogbo, Ikponmwosa Jude Ogieuhi, David Isarinade, Bonaventure Ukoaka, Ayodeji Akinmeji, Irene Ajayi, Ezenwoba Chidiogo, Owolabi Samuel, Habeebat Nurudeen-Busari, Abdulbasit Opeyemi Muili and David B. Olawade
    Citation: Clinical Diabetes and Endocrinology 2024 10:18
  39. Sarcopenia and sarcopenic obesity are growing concerns associated with increasing diabetes incidence, but data from Indian diabetic cohorts are limited. This study examined the prevalence and clinical factors ...

    Authors: Yogesh M., Monika G. Patel, Hardik Harshadbhai Makwana and Hardikkumar Kalariya
    Citation: Clinical Diabetes and Endocrinology 2024 10:22
  40. Diabetes presenting in young adults is often challenging to classify. Diabetic ketoacidosis is typically seen in autoimmune type 1 diabetes mellitus and more rarely in young onset type 2 diabetes mellitus. Bet...

    Authors: Xi May Zhen, Stephen M. Twigg, Ted Wu, Eddy Tabet, Margaret J. McGill, Maria Constantino, Amali Mallawaarachchi, Connie Luo, Senthil Thillainadesan, Yusof Rahman and Jencia Wong
    Citation: Clinical Diabetes and Endocrinology 2024 10:17
  41. Type 1 Diabetes (T1D) is associated with increased risk of fractures, worsened by presence of microvascular complications. This study’s objective is to determine the impact of progressive decline in estimated ...

    Authors: Funmbi Babalola, Jill Hamilton, Michael Zappitelli, Yesmino Elia, Jacqueline Curtis, Rahim Moineddin and Farid H. Mahmud
    Citation: Clinical Diabetes and Endocrinology 2024 10:12
  42. Hypertension (HT) is an orchestrator of atherosclerotic cardiovascular disease (ASCVD) in people living with type 2 diabetes (T2D). Control of systolic blood pressure (SBP) and HT as a whole is suboptimal in d...

    Authors: William Lumu, Silver Bahendeka, Davis Kibirige, Ronald Wesonga and Ronald Kasoma Mutebi
    Citation: Clinical Diabetes and Endocrinology 2024 10:16
  43. This mini-narrative review explores the relationship between diabetes and dementia, focusing on the potential mitigating role of metformin in reducing cognitive decline among individuals with type 2 diabetes. ...

    Authors: Nicholas Aderinto, Gbolahan Olatunji, Emmanuel Kokori, Praise Fawehinmi, Abdulrahmon Moradeyo, Stephen Igwe, Rebecca Ojabo, Badrudeen Olalekan Alabi, Emmanuel Chuka Okafor, Damilola Ologbe, Ayobami Olafimihan and David B. Olawade
    Citation: Clinical Diabetes and Endocrinology 2024 10:10
  44. Despite its high prevalence in the western world metabolic dysfunction-associated steatotic liver disease (MASLD) does not benefit from targeted pharmacological therapy. We measured healthcare utilisation and ...

    Authors: Arnaud Nze Ossima, Angélique Brzustowski, Valérie Paradis, Bernard Van Beers, Catherine Postic, Cédric Laouénan, Stanislas Pol, Laurent Castéra, Jean-François Gautier, Sebastien Czernichow, Anais Vallet-Pichard, Etienne Larger, Lawrence Serfaty, Marie Zins, Dominique Valla and Isabelle Durand Zaleski
    Citation: Clinical Diabetes and Endocrinology 2024 10:9
  45. Painful diabetic neuropathy (PDN) is highly prevalent and annoyingly in patients with diabetes. The aim of this study was to investigate the effects of oral N-acetylcysteine (NAC) compared to pregabalin in PDN.

    Authors: Firozeh Sajedi, Arman Abdi, Maryam Mehrpooya, Vida Faramarzi, Younes Mohammadi and Fateme Sheida
    Citation: Clinical Diabetes and Endocrinology 2024 10:15

Annual Journal Metrics

  • Speed 2024
    Submission to first editorial decision (median days): 6
    Submission to acceptance (median days): 75

    Usage 2024
    Downloads: 278,486
    Altmetric mentions: 184